On February 12, 2026, GSK plc granted conditional share awards to key executives under its 2017 Performance Share Plan, with total sales growth and shareholder returns among performance metrics determining vesting. The shares were awarded at £21.50 each for a total of 463,662 shares to the CEO and various other amounts for different executives.